# A Single-Dose Pharmacokinetics Study of Tapimycin Injection

> **NCT00924742** · NA · COMPLETED · sponsor: **Tri-Service General Hospital** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Tapimycin (piperacillin 4 g + tazobactam 0.5g)

## Key facts

- **NCT ID:** NCT00924742
- **Lead sponsor:** Tri-Service General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2009-04
- **Final completion:** 2009-05
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2009-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00924742

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00924742, "A Single-Dose Pharmacokinetics Study of Tapimycin Injection". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00924742. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*